Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Is Coronary Lithotripsy as Effective as Rotational Atherectomy?

Severely calcified lesions currently pose a significant challenge, as they require adequate preparation through non-compliant balloons or cutting balloons to achieve effective stent expansion. Another option is the use of orbital or rotational atherectomy (RA), but this carries the risk of complications such as slow/no reflow, perforations, dissections, peri-procedural infarction, or guidewire rupture.

¿Es la litotricia coronaria tan efectiva como la aterectomía rotacional?

Despite the lack of comparative randomized studies between strategies, intravascular lithotripsy (IVL) has shown benefits in various analyses of severely calcified lesions. 

The ROTA.shock study randomized 61 patients with severely calcified lesions and ischemia. Of these, 31 underwent RA, and 28 underwent IVL. Optical coherence tomography (OCT) was performed at the end of the procedure. The primary endpoint (PEP) was the minimal lumen area (MLA) for the stent at the end of the procedure.

The mean participant age was 73 years old and most of the subjects were men. Overall, 22 patients had diabetes, 58% had hypertension, 41 had a history of myocardial infarction, and 5 of them were smokers. The average ejection fraction was 55%, and 50 patients presented stable coronary syndrome, 2 had unstable angina, 6 experienced non-ST-segment elevation myocardial infarction (NSTEMI), and 1 had an ST-segment elevation myocardial infarction (STEMI).

Predilation was more common in those who underwent IVL. There were no differences in the OCT performed before percutaneous coronary intervention (PCI), with similar levels of calcification and lumen. The maximum calcification angle was 270 degrees, with a thickness of 0.61 mm and a length of 16 mm.

Read also: Optimal Duration of DAPT with Oral Anticoagulation After PCI?: 1 Month vs. 3 Months.

The PEP was lower but not statistically inferior with IVL (mean: 6.10 mm², 95% confidence interval [CI]: 5.32–6.87 mm²) compared with RA (6.60 mm², 95% CI: 5.66–7.54 mm²; difference in MLA: −0.50 mm², 95% CI: −1.52–0.52 mm²; non-inferiority margin: −1.60 mm²). Stent expansion was similar (0.82 vs. 0.83, p=0.79) for IVL and RA, respectively, and there were no differences in contrast volume, received radiation, and procedure time.

Conclusion

In conclusion, coronary lithotripsy did not prove to be inferior in terms of the minimum lumen area for the stent, achieving similar expansion compared with rotational atherectomy. Additionally, there were no significant differences in procedure time, contrast volume, or received radiation.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.

Reference: F. Blachutzik, et al. Catheter Cardiovasc Interv. 2023;102:823–833. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...